个人信息
Personal Information
联系方式
Contact Information
个人简介
Personal Profile
唐忠敏，同济大学医学院长聘副教授，博士生导师，同济大学附属上海市第十人民医院双聘PI，主持国家自然科学基金优秀青年科学基金（海外）、上海市领军人才（海外）、同济大学“青年百人计划”A岗等项目。于2019年在中科院上海硅酸盐研究所取得博士学位，之后在美国哈佛医学院附属布莱根妇女医院（2019-2021）和威斯康辛大学麦迪逊分校（2021-2023）从事博士后研究，研究方向主要是设计并制备“活性”纳米材料应用于抗肿瘤，糖尿病血糖控制及mRNA递送等领域的研究。2017 年至今，在Nat. Rev. Mater., Chem. Rev., PNAS, Chem. Soc. Rev., Adv. Mater.,Angew. Chem. Int. Ed., Matter 等顶尖期刊发表论文 50余篇，被引用 7500 余次（h-index=37），7 篇论文入选 ESI高被引论文，授权一项中国发明专利，申请三项美国发明专利。目前担任 Journal of Nanobiotechnology(中科院一区，IF=10.6) 的副主编，Coordination Chemistry Reviews(中科院一区，IF=20.3) 的Guest Editor。同时也是 Nature Communications, ChemicalSociety Reviews, Bioactive Materials; Journal of Nanobiotechnology等杂志的审稿人。
详情请见www.zhongmintanglab.com
上传附件
支持扩展名：.rar .zip .doc .docx .pdf .jpg .png .jpeg上传附件
支持扩展名：.rar .zip .doc .docx .pdf .jpg .png .jpeg上传附件
支持扩展名：.rar .zip .doc .docx .pdf .jpg .png .jpeg【研究方向】
依托同济大学和附属医院的多学科交叉特色，医工理融合，围绕“活性”纳米材料开展三个方向研究：
1. “活性”纳米材料结合催化医学在肿瘤、心血管疾病、糖尿病等方面的研究；
2. 设计合成新型脂质“活性”纳米材料用于RNA的递送；
3. RNA递送结合基因编辑技术的生物医学应用研究。
1. Z. Tang, N. Kong, X. Zhang, Y. Liu, P. Hu,S. Mou, P. Liljeström, J. Shi, W. Tan, J. S. Kim, Y. Cao, R. Langer, K. W.Leong, O. C. Farokhzad*, W. Tao*. (2020) A materials-science perspective ontackling COVID-19. Nature Reviews Materials 5 (11), 847-860. (Front Cover)
2. Z Tang, P Zhao, H Wang, Y Liu*, W Bu*.(2021) Biomedicine meets Fenton chemistry. Chemical Reviews. 121, 4, 1981–2019. (High cited paper) (Front Cover)
3. Y. Xiao, Z. Tang (Co-first), X. Huang, W.Chen, J. Zhou, H. Liu, C. Liu, N. Kong*, W. Tao* (2022) Emerging mRNAtechnologies: delivery strategies and biomedical applications. Chemical SocietyReview, 51, 3828-3845. (Front Cover)
4. Z. Tang, X. You, Y. Xiao, W. Chen, Y. Li, X.Huang, H. Liu, F. Xiao, C. Liu, S. Koo, N. Kong, W. Tao*. (2023) Inhaled mRNAnanoparticles dual-targeting cancer cells and macrophages in the lung foreffective transfection. PNAS 120 (44), e2304966120.
5. Z. Tang*, F. Yu, J. Hsu, J. Shi, W. Cai*.(2024) Soybean oil-derived lipids for efficient mRNA delivery. AdvancedMaterials, 36 (13), 2302901.
6. Z. Tang, H Zhang, Y Liu, D Ni, H Zhang, JZhang, Z Yao, M He, J Shi, W Bu*. (2017) Antiferromagnetic pyrite as the tumormicroenvironment‐mediated nanoplatformfor self‐enhanced tumor imaging and therapy. AdvancedMaterials 29 (47), 1701683. (High cited paper)
7. Z Tang, Y Liu, D Ni, J Zhou, M Zhang, PZhao, B Lv, H Wang, D Jin, W Bu*. (2020) Biodegradable Nanoprodrugs: “Delivering”ROS to Cancer Cells for Molecular Dynamic Therapy. Advanced Materials 32 (4),1904011.
8. Z Tang, Y Liu, M He, W Bu*. (2019)Chemodynamic therapy: tumour microenvironment-mediated Fenton and Fenton‐like reactions. Angewandte Chemie InternationalEdition 58 (4), 946-956. (High cited paper)
9. P. Zhao, Y. Jiang, Z. Tang*, Y. Li, B. Sun,Y. Wu, J. Wu, Y. Liu*, W. Bu*. (2021) Constructing Electron lever in PerovskiteNanocrystal to Regulate Local Electron Density for Intensive ChemodynamicTherapy. Angewandte Chemie 133(16), 8987-8994.
10. Y. Xiao, Z. Tang (Co-first), X. Huang, J.Joseph, W. Chen, J. Zhou, N. Kong, N. Joshi, J. Du, W. Tao* (2021)Glucose-responsive oral insulin delivery platform for one treatment a day indiabetes. Matter 4(10). 3269-3285.
11. Wu S, Xu T, Gao J, Zhang Q, Huang Y, Liu Z,Hao X, Yao Z, Hao X, Wu PY, Wu Y*, Yin B*, Tang Z*. (2024). Non-invasivediagnosis of liver fibrosis via MRI using targeted gadolinium-basednanoparticles. European Journal of Nuclear Medicine and Molecular Imaging,1-14.
文件上传中...
同济大学
